首页 | 本学科首页   官方微博 | 高级检索  
     


Metabolic syndrome: pathogenesis, medical care and dental implications
Authors:Friedlander Arthur H  Weinreb Jane  Friedlander Ida  Yagiela John A
Affiliation:Graduate Medical Education, VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA. arthur.friedlander@med.va.gov
Abstract:BACKGROUND: The dental literature contains little information about metabolic syndrome (MetS) and its dental implications. TYPES OF STUDIES REVIEWED: The authors conducted a MEDLINE search for the period 2000 through 2005, using the term "metabolic syndrome" to define its pathophysiology, medical treatment and dental implications. RESULTS: MetS is the co-occurrence of abdominal obesity, hyper-triglyceridemia, reduced high-density lipoprotein cholesterol levels, hypertension and impaired fasting glucose, which results from consumption of a high-calorie diet and decreased levels of physical activity superimposed on the appropriate genetic setting. Components of MetS synergistically promote the development of atherosclerosis, resulting in myocardial infarction and stroke. CLINICAL IMPLICATIONS: Deteriorating oral health status is associated with worsening of the atherogenic profile. Tooth loss often results in chewing difficulties because of inadequate occlusive surfaces and may lead to alterations in food selection and dietary quality. This, in turn, adversely affects body composition and nutritional status, both of which are related to vascular health. Dentists should develop treatment plans that preserve and restore the dentition, thus ensuring maximum masticatory efficiency and affording patients the optimum opportunity to consume food that will not foster atherogenesis.
Keywords:Hypertension  obesity  atherosclerosis  metabolic syndrome  ACE"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  cekeyw60"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  Angiotensin-converting enzyme  BMI"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  cekeyw80"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  Body mass index  CYP3A4"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  cekeyw100"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  Cytochrome P450 isoform 3A4  FDA"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  cekeyw120"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  Food and Drug Administration  FFAs"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  cekeyw140"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  Free fatty acids  HDL-C"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  cekeyw160"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  High-density lipoprotein cholesterol  IR"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  cekeyw180"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  Insulin resistance  LDL"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  cekeyw200"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  Low-density lipoprotein  LDL-C"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  cekeyw220"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  Low-density lipoprotein cholesterol  MetS"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  cekeyw240"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  Metabolic syndrome  NHANES III"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  cekeyw260"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  Third National Health and Nutrition Examination Survey  PDGF"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  cekeyw280"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  Platelet-derived growth factor
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号